Antagonist

Results: 956



#Item
601Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Add to Reading List

Source URL: www.fda.gov

Language: English
602Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

Add to Reading List

Source URL: www.fda.gov

Language: English
603Bulletin # 882  February 25, 2014 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick

Bulletin # 882 February 25, 2014 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick

Add to Reading List

Source URL: www.gnb.ca

Language: English - Date: 2014-03-13 10:25:06
604HIGHLIGHTS OF PRESCRIBING INFORMATION  These highlights do not include all the information needed to use Tekturna® safely and effectively. See full prescribing information for Tekturna. Tekturna (aliskiren) Tablets, Ora

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Tekturna® safely and effectively. See full prescribing information for Tekturna. Tekturna (aliskiren) Tablets, Ora

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-11-16 14:35:55
605HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. These highlights do not include all

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use TRELSTAR safely and effectively. See full prescribing information for TRELSTAR. These highlights do not include all

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2013-03-15 15:20:35
606ER Binding Assay Fact Sheet

ER Binding Assay Fact Sheet

Add to Reading List

Source URL: www.epa.gov

Language: English - Date: 2008-03-24 10:32:08
607AR Binding Assay Fact Sheet

AR Binding Assay Fact Sheet

Add to Reading List

Source URL: epa.gov

Language: English - Date: 2008-03-24 10:32:06
608Draft Report on the Current Status of Test Methods for Detecting Endocrine Disruptors: In Vitro Estrogen Receptor Transcriptional Activation Assays - April 2002

Draft Report on the Current Status of Test Methods for Detecting Endocrine Disruptors: In Vitro Estrogen Receptor Transcriptional Activation Assays - April 2002

Add to Reading List

Source URL: epa.gov

Language: English - Date: 2007-11-01 13:24:47
609Drug Decision Summary palonosetron injection

Drug Decision Summary palonosetron injection

Add to Reading List

Source URL: www.health.gov.bc.ca

Language: English - Date: 2014-03-05 12:02:51
610ER Binding Assay Fact Sheet

ER Binding Assay Fact Sheet

Add to Reading List

Source URL: epa.gov

Language: English - Date: 2008-03-24 10:32:08